Low-Carb vs Low-Fat: What Decades of Trials Converged On
The biggest head-to-head diet trial ever run found near-identical weight loss. The real variable turned out to be the person, not the macro.
Few arguments in nutrition have generated more furniture-throwing certainty than low-carb versus low-fat. For years, entire book franchises were built on the claim that one macronutrient was secretly responsible for the obesity epidemic while the other was safe to eat freely. Then someone actually ran the trial at scale, and the answer turned out to be less dramatic than either camp wanted.
That trial is DIETFITS, a year-long randomised study out of Stanford that assigned several hundred adults to either a healthy low-fat or a healthy low-carb diet, with no calorie counting required for either group. According to an analysis of the trial, the two groups lost almost identical amounts of weight over twelve months, roughly five to six kilograms on average, with no statistically significant difference between them.
What DIETFITS actually tested
The trial's design mattered as much as its result. Both diet arms were built around whole, minimally processed foods rather than packaged low-fat or low-carb products, and participants were coached to find a version of the diet that fit their preferences rather than forced onto a rigid macro target. That is a meaningful departure from older, more mechanical trials that simply assigned a fixed carbohydrate or fat percentage regardless of what a person actually enjoyed eating or could sustain.
The headline finding, that neither approach reliably beat the other for weight loss over a year, has been echoed across multiple independent meta-analyses rather than resting on one study alone.
What the broader meta-analyses add
A systematic review and meta-analysis of low-carbohydrate versus low-fat diets in people with type 2 diabetes, published in a peer-reviewed diabetes journal, found that low-carbohydrate diets produced short-to-intermediate term reductions in body weight, BMI, fasting insulin and triglycerides, alongside increases in total cholesterol and HDL cholesterol. Those are real, measurable short-term advantages, but the same body of literature shows the gap narrows over longer follow-up.
That pattern, a short-term edge for low-carb that fades with time, shows up again in a separate meta-analysis of randomised controlled trials in overweight and obese adults, summarised in a review of metabolic risk factors: low-carbohydrate diets were associated with moderately greater weight loss than diets without carbohydrate restriction in the short term, but that difference tends to disappear over longer periods, with outcomes at 24 months converging to roughly the same place regardless of which diet a person started on. A dietary intervention meta-analysis published in PLOS One comparing low-carbohydrate and low-fat diets in overweight and obese adults reported the same broad convergence once the trial window extended beyond a year.
So what actually predicts success
If the macronutrient split is not the deciding factor, something else has to explain why some people lose substantial weight on a given diet and others regain it within a year. The evidence increasingly points toward adherence, whether a person can actually keep eating this way for months rather than weeks, as the dominant variable. A diet that a person finds tolerable and can sustain will outperform, in practice, a theoretically superior diet abandoned after six weeks. This is echoed across the meta-analytic literature: authors reviewing both low-carb and low-fat trial data have generally concluded that people should choose based on personal preference, health goals, and what fits their life, rather than searching for a universally superior macronutrient ratio.
There are exceptions worth naming. People with type 2 diabetes may see meaningfully better short-term glycemic control on a lower-carbohydrate pattern, which is one reason lower-carbohydrate approaches remain a legitimate option within current diabetes nutrition guidance rather than a fringe idea. Athletes with high glycogen demands, and people managing certain lipid disorders, are other groups where the macronutrient split can matter more than it does for a general population trying to lose weight.
This article reports on published trial and meta-analysis data and is not medical advice. Anyone with diabetes, kidney disease, or a lipid disorder should discuss a significant shift toward either low-carbohydrate or low-fat eating with a physician or registered dietitian, since these changes can affect medication needs and are not universally appropriate.
Decades of trial data have not produced a macronutrient winner because there may not be one to find, at least not at the population level. What they have produced is a more useful, if less headline-friendly, conclusion: pick the pattern built on real food that a person can actually keep eating, and the biology tends to take care of itself.
Published in The Outspoken Digest
Read Next
More Nutrition →
Plant Protein Versus Animal Protein: What Actually Matters in a Real Diet
Mar 12, 2026/4 min read
